Transactions
Clinilabs recapitalized by InTandem Capital Partners
Nov. 2024
Client: Clinilabs is a science-driven, full-service clinical research organization (“CRO”) focused on providing central nervous system (“CNS”) therapeutic development services to pharmaceutical sponsors, medical device innovators, and technology companies. The Company provides end-to-end clinical development services, from First-in-Human Phase I to Pivotal Phase III projects across neurology, psychiatry, substance abuse, and other complex CNS indications.
Role: Edgemont Partners acted as exclusive financial advisor to Clinilabs in its recapitalization by InTandem Capital Partners.
Location: Eatontown, NJ
Sector: Pharmaceutical Services
Lead Banker: David Blume
recapitalized by
